Salarius Pharmaceuticals, Inc. (SLRX) Misses Q1 EPS by 212c
Tweet
Share
E-mailGet Alerts SLRX Hot Sheet
Join SI Premium – FREE
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) reported Q1 EPS of ($2.23), $2.12 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Salarius Pharmaceuticals, Inc. (SLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- BMO cautious on softlines, bearish on athletic names
- Goldman Sachs Reiterates Buy Rating on Braze Inc (BRZE)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
